The recent pattern of a Saudi MERS-CoV case or two a day changed today, as the country's Ministry of Health (MOH) confirmed 6 new cases, 3 of them in Taif and 1 of those fatal.
The national count of confirmed enterovirus D68 (EV-D68) cases reached 160 in 22 states on Sep 19, which is seven more cases and three more states than reported a day earlier, according to the Centers for Disease Control and Prevention (CDC).
Response to the West African Ebola outbreak and other global health emergencies by the World Health Organization (WHO) has been hampered by substantial budget cuts in recent years, The New York Times reported yesterday.
A chikungunya candidate vaccine developed using noninfectious virus-like particles (VLPs) has been shown to provide long-term protection against multiple genotypes of the disease, according to results of the first human trial, conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and published today in The Lancet.
Long-term treatment with a newer artemisinin-based combination drug for malaria, dihydroartemisinin-piperaquine (DP), substantially and safely reduces the risk of malaria in young children, according to a study funded by the National Institutes of Health (NIH) and published online yesterday in PLoS Medicine.
The steady flow of imported chikungunya infections linked mainly to travel to the Caribbean continued in the United States last week, with 98 more cases reported, lifting the total to 398, the US Centers for Disease Control and Prevention (CDC) said yesterday.
With the continuing spread of Ebola virus disease (EVD) in West Africa, the US Centers for Disease Control and Prevention (CDC) yesterday issued an official advisory for US HCWs to consider EVD and possible isolation pending diagnosis in patients who have Ebola-like symptoms and a travel history to affected countries within the previous 21 days.
Novartis and Pfizer today announced that they have submitted applications to the US Food and Drug Administration (FDA) for marketing approval of their vaccines against Neisseria meningitidis serogroup B infection.
The number of patients sickened by H7N9 influenza in China grew by three over the past 3 days, according to reports from three different provinces.
One case is in a 35-year-old woman from Jiangsu province who is hospitalized in critical condition, according to an Apr 19 health department statement translated and posted by FluTrackers, an infectious disease news message board.
Cases of chikungunya in the Caribbean have reached 19,682, according to data today from the European Centre for Disease Prevention and Control (ECDC), up from 18,493 cases a week ago.
